Enlightenment through smart measurements

Open menu

News & Events

Wednesday, April 21, 3:30 p.m. ET – Louis Laflamme, President and CEO, presents at Bloom Burton & Co. Healthcare Investor Conference

15 April 2021

Click on the link to register and to join on the date and hour of the presentation Wednesday, April 21, 3:30 p.m. ET – Louis Laflamme, President and CEO, presents at Bloom Burton & Co. Healthcare Investor Conference  

OpSens Announces Q2 Fiscal 2021 Financial Results and Record FFR and dPR Revenues

14 April 2021

  OpSens Announces Q2 Fiscal 2021 Financial Results and Record FFR and dPR Revenues Quebec City, Quebec, April 14, 2021 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF), a medical device cardiology-focused company delivering diagnostic and treatment solutions based on its proprietary optical technology, today reported its financial results for the second quarter of fiscal…

Read more

OpSens AWARDED INNOVATIVE TECHNOLOGY CONTRACT BY VIZIENT FOR OPTOWIRE III

7 April 2021

OPSENS AWARDED INNOVATIVE TECHNOLOGY CONTRACT BY VIZIENT FOR OPTOWIRE III  Contract awarded for products that bring improvement to health care industry   Quebec City, Quebec, April 7, 2021 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF), a medical device cardiology-focused company, announced today it has been awarded an Innovative Technology  contract from Vizient, Inc.,…

Read more

OpSens to Host Second Quarter Fiscal Year 2021 Financial Results Conference Call on Wednesday, April 14, 2021 – Conference call to be conducted at 11:00 am ET

6 April 2021

OpSens to Host Second Quarter Fiscal Year 2021 Financial Results Conference Call on Wednesday, April 14, 2021 Conference call to be conducted at 11:00 am ET Quebec City, Quebec, April 6, 2021 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF), a medical device cardiology-focused company delivering diagnostic and treatment solutions based on its proprietary optical…

Read more

OpSens to Present at Lytham Partners Spring 2021 Investor Conference – Presentation at 9:30 a.m. ET on Tuesday, March 30, 2021

22 March 2021

OpSens to Present at Lytham Partners Spring 2021 Investor Conference Presentation at 9:30 a.m. ET on Tuesday, March 30, 2021 Quebec City, Quebec, March 22, 2021 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF),  a medical device cardiology-focused company commercializing a  second-generation fiber optic pressure guidewire to diagnose and treat coronary disease, announced today…

Read more

Article Journal de Québec – OpSens Médical: une technologie prometteuse qui ne tient qu’à un fil

1 March 2021

2021-02-28_JdeQ_OpSens Medical_une technologie prometteuse qui ne tient qua un fil

OpSens: Closing of $28.75 M Bought Deal Public Offering – Including $3.75 M Over-Allotment Option Exercised in Full

25 February 2021

OpSens Announces Closing of $28.75 M Bought Deal Public Offering Including $3.75 M Over-Allotment Option Exercised in Full   THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES Quebec City, Canada, February 25, 2021 – OpSens Inc….

Read more

OpSens Obtains CE Marking for the OptoWire III

18 February 2021

OpSens Obtains CE Marking for the OptoWire III   Quebec City, Quebec, February 18, 2021 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF), a medical device cardiology-focused company commercializing a second-generation fiber optic pressure guidewire to diagnose and treat coronary disease, has announced it has received CE marking for the OptoWire III, the latest…

Read more

OpSens Solutions Fiber Optic Sensing Technology Selected for the International Thermonuclear Experimental Reactor (ITER)

8 February 2021

OpSens Solutions Fiber Optic Sensing Technology Selected for the International Thermonuclear Experimental Reactor (ITER) Quebec City, Quebec, February 8, 2021 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) today announced that OpSens Solutions Inc. (“OpSens Solutions”), its wholly-owned subsidiary focused on applying the Company’s proprietary and innovative fiber optic measurement solutions to industrial applications,…

Read more

OpSens Announces $25 Million Bought Deal Offering

5 February 2021

OPSENS INC. ANNOUNCES $25 MILLION BOUGHT DEAL OFFERING   THIS NEWS RELEASE IS INTENDED FOR DISTRIBUTION IN CANADA ONLY AND IS NOT INTENDED FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES. Québec City, Canada, February 5, 2021 – OpSens Inc. (“OpSens” or the “Company”) (TSX:OPS) (OTCQX:OPSSF) announced today that it…

Read more